Philippe G. Nantermet

Author

Also Known As

Nantermet, P.G., P. G. NANTERMET, P. Nantermet, P.G. Nantermet, Philippe G Nantermet, Philippe G. Nantermet, Philippe Nantermet, Philippe G. Nantermet, Philippe G. Nantermet

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Synaptic Research (United States)Ludwig-Maximilians-Universität München University of North Carolina at Chapel Hill

About

Philippe G. Nantermet is an author at United States Military Academy specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	1K
2	Biochemistry	15	16	750
3	Natural Sciences	14	15	732
4	Biomolecular Engineering	7	7	375
5	Engineering	5	5	251

Philippe G. Nantermet

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules A. Buitrago Santanilla, Erik L. Regalado, Tony Pereira, Science	2014	635
In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α<sub>1A</sub> Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia James C. Barrow, Philippe G. Nantermet, Harold G. Selnick, Journal of Medicinal Chemistry Molecular PharmacologyUrologyPharmacological StudyFunctional SelectivityVivo Evaluation	2000	220
The Total Synthesis of (±)-Ginkgolide B Michael T. Crimmins, Jennifer M. Pace, Philippe G. Nantermet, Journal of the American Chemical Society Medicinal ChemistryGinkgolide BBioorganic ChemistryHeterocyclicBiochemistry	2000	105
First Demonstration of Cerebrospinal Fluid and Plasma Aβ Lowering with Oral Administration of a β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates Sethu Sankaranarayanan, Marie A. Holahan, Dennis Colussi, Journal of Pharmacology and Experimental Therapeutics	2008	105
Discovery and Evaluation of Potent P<sub>1</sub> Aryl Heterocycle-Based Thrombin Inhibitors Mary Beth Young, James C. Barrow, Kristen L. Glass, Journal of Medicinal Chemistry Molecular DockingCombinatorial ChemistryMedicinal ChemistryThrombin KDrug Target	2004	93
Discovery of Oxadiazoyl Tertiary Carbinamine Inhibitors of β-Secretase (BACE-1) Hemaka A. Rajapakse, Philippe G. Nantermet, Harold G. Selnick, Journal of Medicinal Chemistry	2006	82
Modeling a Crowdsourced Definition of Molecular Complexity Robert P. Sheridan, Nicolas F. Zorn, Edward C. Sherer, Journal of Chemical Information and Modeling	2014	81
A facile three-step synthesis of 1,2-amino alcohols using the Ellman homochiral tert-butylsulfinamide James C. Barrow, Phung L. Ngo, Janetta M. Pellicore, Tetrahedron Letters EngineeringEllman Homochiral Tert-butylsulfinamide1,2-Amino AlcoholsFacile Three-step SynthesisPeptide Synthesis	2001	75
Synthesis of Complex Druglike Molecules by the Use of Highly Functionalized Bench‐Stable Organozinc Reagents Thomas J. Greshock, Keith P. Moore, Ray T. McClain, Angewandte Chemie International Edition Combinatorial ChemistryBioorganic ChemistryChemical AnalysisOrganic ChemistryChemistry	2016	61
Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformation Shaun R. Stauffer, Matthew G. Stanton, Alison R. Gregro, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryIsonicotinamide Bace-1 InhibitorsNatural Sciences	2006	60

Page 1